← Leaderboards
Anu Mathew
Meso Scale Diagnostics, Llc
$3,620,160
Attributed
$3,719,788
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $906.7K · FY2008–19$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,719,788 · 6
By mechanism
U24$1,899,537 · 1
N44$756,981 · 1
R43$714,335 · 2
R41$199,257 · 1
N43$149,678 · 1
Top collaborators
- Radoslav Goldman1 shared
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingDiagnosticTechnologyValidationUniversitiesSensitivity And SpecificityAntigensSerumAutoimmune ResponsesPerformanceDetectionBaseAutoantibodiesSerologicalBiological MarkersAutoimmune ProcessPlasmaLaboratoriesProtocols DocumentationSpecificityAssay DevelopmentDiabetes MellitusCohortCeliac Disease
Grant awards (11)
Highly Sensitive and Specific MSD Multiplexed Autoimmune Disease Panel$365,689
U24 · FY2019 · AI · contact PI
Highly Sensitive and Specific MSD Multiplexed Autoimmune Disease Panel$372,825
U24 · FY2018 · AI · contact PI
Highly Sensitive and Specific MSD Multiplexed Autoimmune Disease Panel$378,850
U24 · FY2017 · AI · contact PI
Highly Sensitive and Specific MSD Multiplexed Autoimmune Disease Panel$386,814
U24 · FY2016 · AI · contact PI
Highly Sensitive and Specific MSD Multiplexed Autoimmune Disease Panel$395,359
U24 · FY2015 · AI · contact PI
Non-radioactive Multiplexed Assays for Prediction/Diagnosis of T1D and Comorbid A$289,110
R43 · FY2013 · DK · contact PI
Non-radioactive Multiplexed Assays for Prediction/Diagnosis of T1D and Comorbid A$295,552
R43 · FY2012 · DK · contact PI
TAS::75 0849::TAS PHARMACODYNAMIC ASSAYS FOR CANCER THERAPEUTICS$756,981
N44 · FY2010 · CA · contact PI
TAS::75 0849::TAS PHARMACODYNAMIC ASSAYS FOR WNT/FRIZZLED AND HGF/C-MET SIGNALIN$149,678
N43 · FY2010 · CA · contact PI
Multiplex Electroluminescent Assay for Detection of Hepatocellular Carcinoma$199,257
R41 · FY2008 · CA · contact PI
Multiplexed biomarker panels for early detection of prostate cancer$129,673
R43 · FY2008 · CA · contact PI